Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2014 | 03-2014 | |
| Sales | 247 | 1 |
| Operating Expenses | 832 | 99 |
| Operating Income | -584 | -98 |
| Interest Expense | 5 | 19 |
| Other Income | 985 | 41 |
| Pre-tax Income | 396 | -76 |
| Income Tax | 5 | 0 |
| Net Income Continuous | 391 | -76 |
| Net Income | $391 | $-76 |
| EPS Basic Total Ops | 0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.01 | -0.01 |
| EPS Diluted Total Ops | 0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.01 | -0.01 |
| EBITDA(a) | $433 | $-50 |